IBDEI1SQ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30070,0)
 ;;=D56.3^^135^1372^180
 ;;^UTILITY(U,$J,358.3,30070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30070,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,30070,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,30070,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,30071,0)
 ;;=D56.9^^135^1372^181
 ;;^UTILITY(U,$J,358.3,30071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30071,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,30071,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,30071,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,30072,0)
 ;;=M31.1^^135^1372^183
 ;;^UTILITY(U,$J,358.3,30072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30072,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,30072,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,30072,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,30073,0)
 ;;=D51.2^^135^1372^184
 ;;^UTILITY(U,$J,358.3,30073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30073,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,30073,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,30073,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,30074,0)
 ;;=D05.92^^135^1372^33
 ;;^UTILITY(U,$J,358.3,30074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30074,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,30074,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,30074,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,30075,0)
 ;;=D05.91^^135^1372^35
 ;;^UTILITY(U,$J,358.3,30075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30075,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,30075,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,30075,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,30076,0)
 ;;=D05.90^^135^1372^31
 ;;^UTILITY(U,$J,358.3,30076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30076,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,30076,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,30076,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,30077,0)
 ;;=D51.0^^135^1372^185
 ;;^UTILITY(U,$J,358.3,30077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30077,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,30077,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,30077,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,30078,0)
 ;;=D51.1^^135^1372^186
 ;;^UTILITY(U,$J,358.3,30078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30078,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
 ;;^UTILITY(U,$J,358.3,30078,1,4,0)
 ;;=4^D51.1
 ;;^UTILITY(U,$J,358.3,30078,2)
 ;;=^5002285
 ;;^UTILITY(U,$J,358.3,30079,0)
 ;;=D51.9^^135^1372^188
 ;;^UTILITY(U,$J,358.3,30079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30079,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,30079,1,4,0)
 ;;=4^D51.9
 ;;^UTILITY(U,$J,358.3,30079,2)
 ;;=^5002289
 ;;^UTILITY(U,$J,358.3,30080,0)
 ;;=D68.0^^135^1372^190
 ;;^UTILITY(U,$J,358.3,30080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30080,1,3,0)
 ;;=3^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,30080,1,4,0)
 ;;=4^D68.0
 ;;^UTILITY(U,$J,358.3,30080,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,30081,0)
 ;;=C88.0^^135^1372^191
 ;;^UTILITY(U,$J,358.3,30081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30081,1,3,0)
 ;;=3^Waldenstrom Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,30081,1,4,0)
 ;;=4^C88.0
 ;;^UTILITY(U,$J,358.3,30081,2)
 ;;=^5001748
 ;;^UTILITY(U,$J,358.3,30082,0)
 ;;=C91.02^^135^1372^3
 ;;^UTILITY(U,$J,358.3,30082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30082,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Relapse
 ;;^UTILITY(U,$J,358.3,30082,1,4,0)
 ;;=4^C91.02
